QUOTED. 10 October 2019. Mark Leahey.
Executive Summary
The Medical Device Manufacturers Association has advised the US Medicare agency to consult closely with orthopedic societies before finalizing a proposal to permit outpatient facilities and ambulatory surgery centers from performing knee and hip procedures. See what MDMA president and CEO Mark Leahey said about it here.
“MDMA recommends that CMS consult closely with surgeons and their representative organizations regarding the clinical suitability of both of these proposals. It is imperative that surgeons continue to have the option to select the appropriate [surgical] setting.” – Mark Leahey, president and CEO, Medical Device Manufacturers Association (MDMA)
- Find out more: Work With Specialty Societies Before Taking Hip And Knee Procedures Off IPO-Only List, MDMA Advises CMS
Click here for a free trial of Medtech Insight